Children and youth with diabetes are not at increased risk for hospitalization due to COVID‐19

The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), responsible for the coronavirus disease COVID‐19, was first identified in Wuhan, China in December 2019. Diabetes, as well as other cardiovascular comorbidities, has been recognized as a major risk factor for outcomes and mortality in...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric diabetes 2021-03, Vol.22 (2), p.202-206
Main Authors: Cardona‐Hernandez, Roque, Cherubini, Valentino, Iafusco, Dario, Schiaffini, Riccardo, Luo, Xiaoping, Maahs, David M
Format: Article
Language:English
Subjects:
Adolescent
Asymptomatic
Child
Children
Children & youth
Clinical Care and Technology
Comorbidity
Coronaviridae
Coronaviruses
COVID-19
COVID-19 - epidemiology
Diabetes
Diabetes mellitus (insulin dependent)
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Global Health
Hospitalization - statistics & numerical data
Humans
Medical prognosis
outcome
Pandemics
prognosis
Risk Factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
type 1 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), responsible for the coronavirus disease COVID‐19, was first identified in Wuhan, China in December 2019. Diabetes, as well as other cardiovascular comorbidities, has been recognized as a major risk factor for outcomes and mortality in adults with COVID‐19, particularly in the elderly with type 2 diabetes. Based on these conclusions, COVID‐19 data on adults have been generalized to youth with diabetes. Nevertheless, experience from pediatric diabetes practices in China (Wuhan), Italy, Spain (Catalonia), and the United States (San Francisco Bay Area) consistently report only a single severe case of COVID‐19 in a 20‐year‐old female youth with type 1 diabetes (T1D) that was hospitalized for bilateral pneumonia and was subsequently discharged without complications. In Italy, information on COVID‐19 in all children with diabetes is collected on a weekly basis and those with positive swab test or infection‐related symptoms reported to a dedicated national registry. Of a total of 15 500 children tested, 11 subjects with T1D (age 8‐17y) tested positive for COVID‐19; 6/11 were asymptomatic and the rest presented with mild symptoms. In the rest of locations, youths with T1D diagnosed with COVID‐19 were based on clinical suspicion and a confirmatory PCR test (Wuhan:0; Catalonia‐HSJD:3; California‐Stanford:2). All of them were asymptomatic or had a mild course. We suggest that COVID‐19 data from adults should not be generalized to children, adolescents, and youth with diabetes as their outcomes and prognosis seem to be similar to their non‐diabetic‐peers and consistently milder than adults with diabetes.
ISSN:1399-543X
1399-5448
DOI:10.1111/pedi.13158